It does not work against certain types of malaria (chloroquine-resistant). The United States Center for Disease Control provides updated guidelines and travel recommendations for the prevention and treatment of malaria in different parts of the world. Does hydroxychloroquine make you gain weight Plaquenil drug manufacturer Chloroquine cataract Hydroxychloroquine med Hydroxychloroquine is a quinoline medicine used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. This medicine is not effective against all strains of malaria. The purpose of this study is to determine the short-term effects of the antimalarial medication, hydroxychloroquine HCQ, compared with placebo using frequently sampled intravenous glucose tolerance testing FSIGTT methodology to study changes in insulin secretion and glucose tolerance in subjects at risk for developing Type 2 diabetes. Plaquenil hydroxychloroquine belongs to a group of medicines called quinolines. Plaquenil is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. This medication is also used, usually with other medications, to treat certain auto-immune diseases (lupus, rheumatoid arthritis) when other medications have not worked or cannot be used. Discuss the most recent information with your doctor before traveling to areas where malaria occurs. Hydroxychloroquine used for diabetes Favorable Effect of Hydroxychloroquine in Patients with., Reducing Risk of Type 2 Diabetes Hydroxychloroquine Use. Plaquenil toxicity heartPlaquenil steven johnson syndromeHydroxychloroquine arthritis Hydroxychloroquine HCQ, a commonly used antimalarial drug in rheumatic diseases, has shown favorable metabolic effects on both glucose control and lipid profiles. We describe a case of a young woman with type 1 diabetes whose glycemic control was optimized with the introduction of HCQ as a treatment for her Sjogren syndrome in addition to a subtle yet measurable improvement in her lipid profile. A favorable effect of hydroxychloroquine on glucose and.. Plaquenil Uses, Dosage & Side Effects -. Hydroxychloroquine Plaquenil Side Effects & Dosage for.. The search was conducted using MeSH terms PubMed and text words for each domain diabetes mellitus and hydroxychloroquine. The search terms used were “diabetes mellitus,” “hyperglycemia,” “insulin resistance,” and “hydroxychloroquine.” The MeSH terms and/or text words were combined by “AND” or “OR” in each domain. Background/Objectives Several studies have associated hydroxychloroquine use with decreased risk of diabetes mellitus diabetes or improved glycemic control in rheumatoid arthritis patients, but the studies were small or used data from self-report. The present study sought to replicate this protective relationship in a health system using electronic health records with laboratory data and physician diagnoses. We recently showed that long-term use of hydroxychloroquine HCQ, an antimalarial used to treat rheumatoid arthritis is associated with an impressive 77% reduction in risk of diabetes when taken for more than 4 years. This protective association increases with greater duration of use.